日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2013/12/17 | 1,948 | 1,970 | 1,924 | 1,936 | -1 | -0.1% | 229,000 |
| 2013/12/16 | 1,995 | 2,000 | 1,935 | 1,937 | -52 | -2.6% | 342,000 |
| 2013/12/13 | 1,941 | 2,001 | 1,940 | 1,989 | +43 | +2.2% | 405,000 |
| 2013/12/12 | 1,932 | 1,956 | 1,930 | 1,946 | -14 | -0.7% | 122,000 |
| 2013/12/11 | 1,989 | 1,989 | 1,950 | 1,960 | -22 | -1.1% | 209,000 |
| 2013/12/10 | 1,980 | 2,000 | 1,973 | 1,982 | -18 | -0.9% | 291,000 |
| 2013/12/09 | 2,043 | 2,052 | 1,985 | 2,000 | -58 | -2.8% | 486,000 |
| 2013/12/06 | 2,100 | 2,111 | 2,045 | 2,058 | -30 | -1.4% | 545,000 |
| 2013/12/05 | 2,034 | 2,095 | 2,028 | 2,088 | +55 | +2.7% | 607,000 |
| 2013/12/04 | 1,991 | 2,042 | 1,938 | 2,033 | +37 | +1.9% | 782,000 |
| 2013/12/03 | 1,945 | 2,010 | 1,937 | 1,996 | +51 | +2.6% | 524,000 |
| 2013/12/02 | 1,878 | 1,954 | 1,878 | 1,945 | +88 | +4.7% | 412,000 |
| 2013/11/29 | 1,880 | 1,883 | 1,845 | 1,857 | -22 | -1.2% | 130,000 |
| 2013/11/28 | 1,870 | 1,894 | 1,867 | 1,879 | +19 | +1% | 213,000 |
| 2013/11/27 | 1,857 | 1,877 | 1,851 | 1,860 | -9 | -0.5% | 235,000 |
| 2013/11/26 | 1,834 | 1,883 | 1,820 | 1,869 | +39 | +2.1% | 345,000 |
| 2013/11/25 | 1,800 | 1,833 | 1,800 | 1,830 | +35 | +1.9% | 219,000 |
| 2013/11/22 | 1,810 | 1,816 | 1,763 | 1,795 | -14 | -0.8% | 205,000 |
| 2013/11/21 | 1,770 | 1,809 | 1,770 | 1,809 | +44 | +2.5% | 238,000 |
| 2013/11/20 | 1,760 | 1,770 | 1,721 | 1,765 | ±0 | ±0% | 129,000 |
| 2013/11/19 | 1,769 | 1,770 | 1,740 | 1,765 | -9 | -0.5% | 124,000 |
| 2013/11/18 | 1,780 | 1,792 | 1,762 | 1,774 | -11 | -0.6% | 179,000 |
| 2013/11/15 | 1,777 | 1,793 | 1,763 | 1,785 | ±0 | ±0% | 241,000 |
| 2013/11/14 | 1,768 | 1,794 | 1,755 | 1,785 | +6 | +0.3% | 239,000 |
| 2013/11/13 | 1,775 | 1,793 | 1,771 | 1,779 | +11 | +0.6% | 253,000 |
| 2013/11/12 | 1,743 | 1,772 | 1,739 | 1,768 | +31 | +1.8% | 316,000 |
| 2013/11/11 | 1,729 | 1,744 | 1,721 | 1,737 | +17 | +1% | 183,000 |
| 2013/11/08 | 1,680 | 1,724 | 1,672 | 1,720 | +66 | +4% | 259,000 |
| 2013/11/07 | 1,636 | 1,663 | 1,634 | 1,654 | +20 | +1.2% | 141,000 |
| 2013/11/06 | 1,615 | 1,664 | 1,615 | 1,634 | -1 | -0.1% | 119,000 |
| 2013/11/05 | 1,689 | 1,689 | 1,625 | 1,635 | -18 | -1.1% | 234,000 |
| 2013/11/01 | 1,690 | 1,690 | 1,644 | 1,653 | -37 | -2.2% | 111,000 |
| 2013/10/31 | 1,691 | 1,708 | 1,688 | 1,690 | ±0 | ±0% | 156,000 |
| 2013/10/30 | 1,706 | 1,718 | 1,687 | 1,690 | -15 | -0.9% | 279,000 |
| 2013/10/29 | 1,697 | 1,713 | 1,676 | 1,705 | +18 | +1.1% | 264,000 |
| 2013/10/28 | 1,675 | 1,696 | 1,674 | 1,687 | +14 | +0.8% | 138,000 |
| 2013/10/25 | 1,710 | 1,710 | 1,670 | 1,673 | -42 | -2.4% | 160,000 |
| 2013/10/24 | 1,693 | 1,720 | 1,680 | 1,715 | +27 | +1.6% | 135,000 |
| 2013/10/23 | 1,718 | 1,722 | 1,686 | 1,688 | -19 | -1.1% | 132,000 |
| 2013/10/22 | 1,709 | 1,715 | 1,700 | 1,707 | -7 | -0.4% | 118,000 |
| 2013/10/21 | 1,710 | 1,720 | 1,700 | 1,714 | +21 | +1.2% | 206,000 |
| 2013/10/18 | 1,677 | 1,696 | 1,671 | 1,693 | +17 | +1% | 113,000 |
| 2013/10/17 | 1,679 | 1,690 | 1,667 | 1,676 | +4 | +0.2% | 98,000 |
| 2013/10/16 | 1,663 | 1,680 | 1,662 | 1,672 | +4 | +0.2% | 108,000 |
| 2013/10/15 | 1,676 | 1,688 | 1,656 | 1,668 | -7 | -0.4% | 299,000 |
| 2013/10/11 | 1,680 | 1,680 | 1,665 | 1,675 | +28 | +1.7% | 182,000 |
| 2013/10/10 | 1,636 | 1,660 | 1,634 | 1,647 | +16 | +1% | 167,000 |
| 2013/10/09 | 1,616 | 1,637 | 1,600 | 1,631 | +20 | +1.2% | 178,000 |
| 2013/10/08 | 1,604 | 1,628 | 1,587 | 1,611 | +9 | +0.6% | 169,000 |
| 2013/10/07 | 1,616 | 1,623 | 1,592 | 1,602 | -15 | -0.9% | 176,000 |
2801～
2850
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 168,300円 | +5.0% | +1.5% | 0.00% | 14.40倍 | 3.83倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
